01/12/2021 3:17 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2021 3:16 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2021 6:32 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2020 6:23 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2020 3:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2020 7:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/19/2020 7:07 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2020 5:27 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:23 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:21 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/16/2020 5:20 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:19 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:16 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:11 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:10 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:08 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 5:02 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2020 3:04 PM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020 3:02 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2020 5:09 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2020 3:05 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:51 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:47 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:40 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:36 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:29 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:24 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:21 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 6:14 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 5:35 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 5:22 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2020 3:45 PM | Neurocrine Biosciences (Filer)
| Form S-8 POS
| |
08/03/2020 3:40 PM | Neurocrine Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/03/2020 3:14 PM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/28/2020 3:10 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2020 3:26 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2020 3:19 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2020 3:15 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2020 6:10 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2020 4:31 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 6:00 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 5:59 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 5:57 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 5:55 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 5:52 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 5:42 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2020 3:09 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2020 6:15 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:59 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2020 7:09 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2020 7:17 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2020 7:06 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2020 3:27 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:46 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:44 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:43 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:42 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:41 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:40 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:38 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:35 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:33 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2020 7:32 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2020 8:48 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2020 3:36 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A
| |
04/09/2020 3:30 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A
| |
04/09/2020 3:11 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2020 7:02 AM | Neurocrine Biosciences (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/11/2020 6:23 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:21 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:17 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:16 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:14 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:13 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:10 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:09 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:08 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 6:06 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2020 6:32 AM | BlackRock Inc. (Filed by) Neurocrine Biosciences (Subject)
| Form SC 13G/A
| |
02/07/2020 5:54 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:50 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:49 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:47 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:46 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:44 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:40 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:38 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:37 PM | Bozigian Haig P. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 5:35 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 6:16 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2020 3:10 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2019 3:14 PM | Neurocrine Biosciences (Filed by) Xenon Pharmaceuticals Inc. (Subject)
| Form SC 13D
| |
12/10/2019 8:43 AM | FMR LLC (Filed by) Neurocrine Biosciences (Subject)
| Form SC 13G/A
| |
12/04/2019 5:06 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2019 4:37 PM | Grigoriadis Dimitri E. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2019 3:41 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2019 3:36 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/04/2019 3:10 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2019 3:20 PM | Lloyd-Smith Malcolm (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2019 5:15 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |